Condition: Nephrotic Syndrome · Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
The goal of this clinical trial is to verify whether a cell culture system can be used to evaluate the presence of a factor capable of causing proteinuria in the serum of patients with primary podocytopathies. This system will also be used to evaluate the in vitro efficacy of a combined therapy for the treatment of this disorder. Researchers will compare samples from patients with primary podocytopathies with those obtained from healthy subjects and patients with other renal disorders. Participants will be asked to visit the clinic at regular intervals for up to 36 months, and to provide blood and urine samples (and a sample of the discarded plasmapheresis effluent in case the procedure is performed).
This description comes directly from the study's public registry record.
Manuel A Podesta', MD, PhD · 0039 0255034568 · manuel.podesta@policlinico.mi.it
Giuseppe Castellano, MD, PhD · giuseppe.castellano@policlinico.mi.it
Always discuss trial participation with your own doctor first.
| Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico | Milan, Italy | Recruiting |
| Fondazione IRCCS Policlinico San Matteo | Pavia, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06718894